Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2018

21.05.2018 | Gynecologic Oncology

Does tumor grade influence the rate of lymph node metastasis in apparent early stage ovarian cancer?

verfasst von: Dimitrios Nasioudis, Spyridon A. Mastroyannis, Emily M. Ko, Nawar A. Latif

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the prevalence of regional lymph node (LN) metastasis in patients with non-clear cell epithelial ovarian cancer apparently confined to the ovary, stratified by tumor grade.

Methods

The National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database was accessed (1988–2014). We identified patients with epithelial ovarian carcinoma of serous, endometrioid and mucinous histology apparently confined to the ovary who underwent extensive lymphadenectomy (defined as at least 20 lymph nodes removed). Demographics, tumor histology, grade and lymph node status were collected. Comparisons were made with Chi square and Mann–Whitney U tests.

Results

A total of 1242 women met the inclusion criteria. Endometrioid adenocarcinoma was the most common histology (564 patients (45.4%)) while 443 (35.7%) and 235 (18.9%) patients had serous, and mucinous adenocarcinoma, respectively. The rate of LN metastasis in low-grade serous was 9.0% (6/67) vs. 14.4% (54/376) in high-grade serous histology (OR, 1.71, 95% CI 0.70, 4.14, p = 0.24). In patients with low-grade endometrioid tumors, the rate of LN metastasis was 1.7% (7/407) vs. 5.1% (8/157) observed in those with high-grade tumors (OR: 3.07, 95% CI 1.09, 8.61, p = 0.033). Lastly, the rate of LN metastasis in mucinous histology was 1.7% (3/177) in low-grade vs. 8.6% (5/58) in high-grade tumors (OR: 5.47, 95% CI 1.27, 23.66, p = 0.024).

Conclusions

Regional LN metastasis in apparent stage I low-grade mucinous and endometrioid ovarian tumors is infrequent.
Literatur
2.
Zurück zum Zitat Young RC (2003) Early-stage ovarian cancer: to treat or not to treat. J Natl Cancer Inst 95(2):94–95CrossRef Young RC (2003) Early-stage ovarian cancer: to treat or not to treat. J Natl Cancer Inst 95(2):94–95CrossRef
4.
Zurück zum Zitat Kleppe M, Wang T, Van Gorp T et al (2011) Lymph node metastasis in stages I and II ovarian cancer: a review. Gynecol Oncol 123(3):610–614CrossRef Kleppe M, Wang T, Van Gorp T et al (2011) Lymph node metastasis in stages I and II ovarian cancer: a review. Gynecol Oncol 123(3):610–614CrossRef
6.
Zurück zum Zitat Cancer Incidence in Five Continents Vol.X IARC Scientific Publication No 164, 2014 Chapter 4, p84 Cancer Incidence in Five Continents Vol.X IARC Scientific Publication No 164, 2014 Chapter 4, p84
7.
Zurück zum Zitat Gockley A, Melamed A, Bregar AJ, Clemmer JT, Birrer M, Schorge JO, Del Carmen MG, Rauh-Hain JA (2017) Outcomes of women with high-grade and low-grade advanced-stage serous epithelial ovarian cancer. Obstet Gynecol 129(3):439–447CrossRef Gockley A, Melamed A, Bregar AJ, Clemmer JT, Birrer M, Schorge JO, Del Carmen MG, Rauh-Hain JA (2017) Outcomes of women with high-grade and low-grade advanced-stage serous epithelial ovarian cancer. Obstet Gynecol 129(3):439–447CrossRef
8.
Zurück zum Zitat Lago V, Minig L, Fotopoulou C (2016) Incidence of lymph node metastases in apparent early-stage low-grade epithelial ovarian cancer: a comprehensive review. Int J Gynecol Cancer. 26(8):1407–1414CrossRef Lago V, Minig L, Fotopoulou C (2016) Incidence of lymph node metastases in apparent early-stage low-grade epithelial ovarian cancer: a comprehensive review. Int J Gynecol Cancer. 26(8):1407–1414CrossRef
9.
Zurück zum Zitat Minig L, Heitz F, Cibula D et al (2017) Patterns of lymph node metastases in apparent stage i low-grade epithelial ovarian cancer: a multicenter study. Ann Surg Oncol 24(9):2720–2726CrossRef Minig L, Heitz F, Cibula D et al (2017) Patterns of lymph node metastases in apparent stage i low-grade epithelial ovarian cancer: a multicenter study. Ann Surg Oncol 24(9):2720–2726CrossRef
10.
Zurück zum Zitat Kaldawy A, Segev Y, Lavie O, Auslender R, Sopik V, Narod SA (2016) Low-grade serous ovarian cancer: a review. Gynecol Oncol 143(2):433–438CrossRef Kaldawy A, Segev Y, Lavie O, Auslender R, Sopik V, Narod SA (2016) Low-grade serous ovarian cancer: a review. Gynecol Oncol 143(2):433–438CrossRef
11.
Zurück zum Zitat Nasioudis D, Chapman-Davis E, Witkin SS et al (2017) Prognostic significance of lymphadenectomy and prevalence of lymph node metastasis in clinically-apparent stage I endometrioid and mucinous ovarian carcinoma. Gynecol Oncol 144(2):414–419CrossRef Nasioudis D, Chapman-Davis E, Witkin SS et al (2017) Prognostic significance of lymphadenectomy and prevalence of lymph node metastasis in clinically-apparent stage I endometrioid and mucinous ovarian carcinoma. Gynecol Oncol 144(2):414–419CrossRef
Metadaten
Titel
Does tumor grade influence the rate of lymph node metastasis in apparent early stage ovarian cancer?
verfasst von
Dimitrios Nasioudis
Spyridon A. Mastroyannis
Emily M. Ko
Nawar A. Latif
Publikationsdatum
21.05.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2018
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-018-4789-2

Weitere Artikel der Ausgabe 1/2018

Archives of Gynecology and Obstetrics 1/2018 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.